I bought Sirius Satellite for $0.15 a share as it was a no brainer when Liberty Media propped it up and squelched the idea of bankruptcy, but the buying opportunity was largely ignored by the investing community. A week earlier shares could have been purchased for $0.04 a share.
What we have here is a bit different, but the gamble is much worth consideration as logic has been discarded.
The company is well positioned and the future looks promising. With revenues growing incrementally, moving to a new headquarters location, possible buyout or merger speculation, this is an exciting time for stockholders.
Never heard of them.
BUZZ-U.S. STOCKS ON THE MOVE-EXELIXIS INC
First Quarter Earnings Announcement Expected: INUV has confirmed that earnings will be announced Wednesday. Followed by a single analyst, forecast earnings are $0.01. The mean has trended upward from the last estimate of $0.00.
Expected Timing: After close
This is a verified date, gathered by Wall Street Horizon callers.
$6's are not out of the question and maybe $5's. The bar has been set high because of the herd mentality running up the price of the stock to irrational and risky levels. Speculation has been dampened by the reality that cancer cures are being solved very difficultly and slowly. The approval time frame is quite long and very expensive to boot.
On April 8, 2015 Inuvo, Inc., and Arkansas Democrat-Gazette, Inc. entered into a Lease Agreement (the “Lease”) for a total of 12,245 square feet of office space located in the Museum Center in Little Rock, Arkansas. The Lease has a term of five years, with two optional five year renewal periods, commencing on the earlier of September 1, 2015 or the date the build-out of the premises is substantially complete. Rent under the Lease is $14,286 per month and increases 2% per annum during the term.
The recent surge in the share price of the company stock has caught the attention of traders and a few large blocks were bought and sold. If the upcoming earnings report meets expectations, then the stock should maintain its value and to continue to climb on the hopes of future growth prospects and increased earnings which I see at my broker which have been forecasted as follows: Q1 2015 $0.01, Q2 2015 $0.01, Q3 2015 $0.02, Q4 2015 $0.04.
First Quarter Earnings Announcement Expected: Earnings will tentatively be announced 04/23/2015. With a single analyst covering INUV, the EPS estimate is $0.01. Expected Timing: After close.
Guidance or news of deals revealed during the conference call would catapult the stock.
Shorting anything and everything was a rewarding strategy in 2007, 2008 and 2009. Currently especially with high beta microcap biotechnology company stocks, it is possible that an investor could be wiped out in one day by an unexpected surge when weighted in a particular equity.